Werewolf Therapeutics Files 8-K
Ticker: HOWL · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1785530
| Field | Detail |
|---|---|
| Company | Werewolf Therapeutics, Inc. (HOWL) |
| Form Type | 8-K |
| Filed Date | Jun 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, filing
TL;DR
Werewolf Therapeutics filed an 8-K on June 13th for events on June 12th - expect updates on corporate actions.
AI Summary
Werewolf Therapeutics, Inc. filed an 8-K on June 13, 2025, reporting events as of June 12, 2025. The filing indicates amendments to articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. Specific details regarding these events, including any financial figures or voting outcomes, are not provided in this excerpt.
Why It Matters
This 8-K filing signals important corporate actions by Werewolf Therapeutics, Inc., which could impact its governance, operations, or financial reporting.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting corporate events without immediate financial implications disclosed in this excerpt.
Key Players & Entities
- Werewolf Therapeutics, Inc. (company) — Registrant
- June 12, 2025 (date) — Earliest event reported
- June 13, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 001-40366 (identifier) — Commission File Number
- 82-3523180 (identifier) — IRS Employer Identification No.
- 200 Talcott Avenue, 2nd Floor Watertown, Massachusetts 02472 (address) — Principal Executive Offices
- (617) 952-0555 (phone_number) — Registrant's telephone number
FAQ
What specific amendments were made to Werewolf Therapeutics' articles of incorporation or bylaws?
The provided excerpt does not specify the nature of the amendments to the articles of incorporation or bylaws.
What matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific matters are not detailed in this excerpt.
What financial statements and exhibits are included in this filing?
The excerpt states that financial statements and exhibits are included, but does not list them.
What is the exact date of the earliest event reported in this 8-K?
The earliest event reported is dated June 12, 2025.
What is the principal executive office address for Werewolf Therapeutics, Inc.?
The principal executive office is located at 200 Talcott Avenue, 2nd Floor Watertown, Massachusetts 02472.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Werewolf Therapeutics, Inc. (HOWL).